Chromatographia

, Volume 36, Issue 1, pp 368–372 | Cite as

Method development and validation procedure for the chromatographic assay of cocaine and its metabolites in pharmacokinetic studies

  • L. Tamisier-Karolak
  • M. Tod
  • O. Petitjean
  • Ph. J. P. Cardot
Article

Summary

Although chromatographic assay is one of the most powerful methods of analysing cocaine and its metabolites in blood samples, the methods presently available for the separation of the metabolites suffer from problems with long-term use for large numbers of assays. We describe the development of a method and devote special attention to the description of the validation procedures of each step of the assay. The validation procedures can be described in two parts. The first is the development of the separation by reversed phase HPLC using the retention properties of cocaine and its major metabolites norcocaine, benzoylecgonine, norbenzoylecgonine as affected by the strength, selectivity and pH of the mobile phase. On a C18, end-capped column, on-column band broadening was limited to the extent that all pairs of peaks are resolved. Extraction from plasma was performed with C18 Bond-Elut and good recovery obtained, without interferences, for all the products under study (cocaine recovery 90.9±6.3%). The internal standard method using atropine has been used for the assay. Validation procedures enbled quantification of cocaine and its main metabolites at concentrations between 50 and 2000 ng/ml.

Key Words

Column liquid chromatography Chromatographic assay Validation Cocaine and its metabolites Pharmacokinetics 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. [1]
    K. A. Loper, Med. Toxicol. Adverse Drug Exp.,4, 174 (1989).Google Scholar
  2. [2]
    J. A. Fleming, R. Byck, P. G. Barash, Anesthesiology,73, 518 (1990)Google Scholar
  3. [3]
    J. J. Ambre, T. J. Connelly, T. I. Ruo, J. Anal. Tox.,15, 17 (1991)Google Scholar
  4. [4]
    J. M. Van Dette, L. A. Cornish, Clinical Pharmacy,8, 401 (1989)Google Scholar
  5. [5]
    J. Ambre, J. Anal. Tox.,9, 241 (1985).Google Scholar
  6. [6]
    J. Y. Zhang, R. L. Foltz, J. Anal. Tox.14, 201 (1990).Google Scholar
  7. [7]
    A. P. Ferko, E. J. Barbieri, D. J. Di Gregorio, Research Communications in Substances of Abuse,11, 11 (1990)Google Scholar
  8. [8]
    B. H. Dvorchik, S. H. Miller, W. P. Graham, J. Chromatogr.,135, 141 (1977)Google Scholar
  9. [9]
    J. Ortuno, R. De la Torre, J. Segura, J. Cami, J. Pharm. Biomed. Anal.,8, 911 (1990).Google Scholar
  10. [10]
    C. E. Lau, F. Ma, J. L. Falk, J. Chromatogr.,531, 95 (1990)Google Scholar
  11. [11]
    J. O. Svensson, J. Anal. Tox.,10, 287 (1986)Google Scholar
  12. [12]
    I. R. Tebbett, Q. W. McCartney, Forensic Sci. Int.,39, 287 (1988)Google Scholar
  13. [13]
    M. Benuck, A. Lajtha, M. E. A. Reith, J. Pharm. & Exp. Therap.,242, 144 (1987)Google Scholar
  14. [14]
    M. Khan, P. K. Gupta, R. Cristie, A. Nangia, H. Winter, F. C. Lam, D. G. Perrier, C. T. Hung, J. Pharm. Sci.,76, 39 (1987)Google Scholar
  15. [15]
    J. Knoll, J. Chromatogr. Sci.,23, 422 (1985)Google Scholar
  16. [16]
    N. Mimura, T. Kinoshita, T. Yoshida, A. Vetake, C. Nakai, Anal. Chem.,60, 2067 (1988)Google Scholar
  17. [17]
    A. Takadate, T. Tahara, H. Fujino, S. Goya, Chem. Pharm. Bull.,30, 4120 (1982)Google Scholar
  18. [18]
    M. A. Moye, A. J. Boning, Anal. Letters.,12, 25 (1979)Google Scholar
  19. [19]
    D. L. Mount, F. C. Churchill, J. Chromatogr.564, 181 (1991)Google Scholar
  20. [20]
    A. Takadate, M. Iwai, H. Fujino, K. Tahara, S. Goya, Yakugaru Zasshi,103, 96 (1983)Google Scholar
  21. [21]
    C. Hamada, M. Iwasaki, N. Kuroda, Y. Ohkura, J. Chromatogr.,341, 426 (1985)Google Scholar
  22. [22]
    S. Ajuha, J. Chromatogr. Sci.,17, 168 (1979)Google Scholar
  23. [23]
    W. G. Galetto, R. E. Kepner, A. D. Webb, Anal. Chem.,38, 34 (1966)Google Scholar
  24. [24]
    J. Jupille, J. Chromatogr. sci.17, 160 (1979)Google Scholar
  25. [25]
    J. Vendrell, F. X. Aviles, J. Chromatogr.,358, 401 (1986)Google Scholar
  26. [26]
    J. Y. Chang, J. Chromatogr.,295, 193 (1984)Google Scholar
  27. [27]
    Y. Zhou, Z. P. Sun, J. Chromatogr.,508, 220 (1990)Google Scholar
  28. [28]
    N. Goto, J. Goto, F. Shamsa, M. Saito, S. Komatsu, K. Suzaki, T. Nambara, Anal. Chem. Acta147, 397 (1983)Google Scholar
  29. [29]
    P. A. Bristow, J. H. Knox, Chromatographia,10, 279 (1977)Google Scholar

Copyright information

© Friedr. Vieweg & Sohn Verlagsgesellschaft mbH 1993

Authors and Affiliations

  • L. Tamisier-Karolak
    • 1
  • M. Tod
    • 2
  • O. Petitjean
    • 2
  • Ph. J. P. Cardot
    • 1
  1. 1.Laboratoire de Chimie Analytique et d'Electrochimie Organiques, Centre d'Etudes PharmaceutiquesUniversité Paris-SudChâtenay-MalabryFrance
  2. 2.Département de PharmacotoxicologieHopital AvicenneBobignyFrance

Personalised recommendations